R. Visscher Et Al. , "Concomitant drug use of nirmatrelvir/ritonavir and CYP3A4-modulating antimicrobial agents: an approach for drug use.," European journal of hospital pharmacy : science and practice , vol.31, no.2, pp.180-182, 2023
Visscher, R. Et Al. 2023. Concomitant drug use of nirmatrelvir/ritonavir and CYP3A4-modulating antimicrobial agents: an approach for drug use.. European journal of hospital pharmacy : science and practice , vol.31, no.2 , 180-182.
Visscher, R., Yalçın, N., Bayraktar, I., & Bayraktar-Ekincioglu, A., (2023). Concomitant drug use of nirmatrelvir/ritonavir and CYP3A4-modulating antimicrobial agents: an approach for drug use.. European journal of hospital pharmacy : science and practice , vol.31, no.2, 180-182.
Visscher, Robbert Et Al. "Concomitant drug use of nirmatrelvir/ritonavir and CYP3A4-modulating antimicrobial agents: an approach for drug use.," European journal of hospital pharmacy : science and practice , vol.31, no.2, 180-182, 2023
Visscher, Robbert Et Al. "Concomitant drug use of nirmatrelvir/ritonavir and CYP3A4-modulating antimicrobial agents: an approach for drug use.." European journal of hospital pharmacy : science and practice , vol.31, no.2, pp.180-182, 2023
Visscher, R. Et Al. (2023) . "Concomitant drug use of nirmatrelvir/ritonavir and CYP3A4-modulating antimicrobial agents: an approach for drug use.." European journal of hospital pharmacy : science and practice , vol.31, no.2, pp.180-182.
@article{article, author={Robbert Visscher Et Al. }, title={Concomitant drug use of nirmatrelvir/ritonavir and CYP3A4-modulating antimicrobial agents: an approach for drug use.}, journal={European journal of hospital pharmacy : science and practice}, year=2023, pages={180-182} }